The Press Room

The Detroit News The TheraBionic P1 device is now available for patients who have advanced liver cancer and have failed first- and second-line therapies. Boris Pasche, M.D., Ph.D., FACP , president and CEO of the Barbara Ann Karmanos Cancer Institute, chair of the Department of Oncology at Wayne State University, and co-inventor of the TheraBionic P1 device, and Anthony Shields, M.D., Ph.D. , medical oncologist and member of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team ,...

The Barbara Ann Karmanos Cancer Institute , the largest provider of cancer care and research in Michigan and part of McLaren Health Care, announced today that the new TheraBionic P1 device, an FDA-approved, at-home treatment , is now available to treat advanced liver cancer. Karmanos Cancer Center is the first institution worldwide to prescribe this treatment. The TheraBionic P1 device is a novel, handheld, portable device that produces low levels of 27.12 MHz radiofrequency electromagnetic fields, whic...

WDET A foundation will offer scholarships and internships to medical students for assistance in recruiting underrepresented and disadvantaged individuals into clinical trials. Hayley Thompson, Ph.D., associate center director of Community Outreach and Education at Karmanos Cancer Institute and faculty supervisor of Karmanos’ Office of Cancer Health Equity and Community Engagement , applauded this work and explained why it's important for patients of color to consider participating in clinical trials. Sh...

Clinical Leader As we approach a new year, Clinical Leader asked clinical trials professionals about the success and future outlook of using decentralized clinical trials (DCT). Wasif Saif, M.D., MBBS , medical oncologist and leader of the Phase I Clinical Trials Multidisciplinary Team at Karmanos, explained how DCTs have provided access to many cancer patients, and what should be considered when designing a trial. Read the article here .

Healio Do you understand how clinical trials work in oncology? Wasif Saif, M.D., MBBS , medical oncologist, leader of the  Phase I Clinical Trials Multidisciplinary Team (MDT) and co-leader of the  Gastrointestinal and Neuroendocrine Oncology MDT , debunked a common myth about clinical trials for cancer and explained why there are no placebos in phase I trials. Read the article here . Learn more about clinical trials at Karmanos here .

WebMD Breast cancer survivors have turned the in-person support group into a thread on Reddit. Researchers at the University of Colorado Anschutz Medical Campus in Denver found themes of advice, affirmation, venting, solidarity, and motivation, among other topics discussed in over 700 posts. Though peer support is present, Mary Morreale, M.D. , clinical psychiatrist and member of the Supportive Oncology Multidisciplinary Team at Karmanos, explained why survivors will need to find a delicate balance with...

Patient Power The liver plays a crucial role in the health of our skin, among its other duties. Anthony Shields, M.D., Ph.D. , medical oncologist and member of the  Gastrointestinal and Neuroendocrine Oncology  and the  Phase 1 Clinical Trials  Multidisciplinary Teams at Karmanos, explained skin conditions that some liver cancer patients may experience. Read the article here .

GQ Anthony Shields, M.D., Ph.D. , medical oncologist and member of the  Gastrointestinal and Neuroendocrine Oncology  and the  Phase 1 Clinical Trials  Multidisciplinary Teams at Karmanos, spoke to GQ about the imaging process for cancer screenings and his thoughts on full-body scans. Read the article here .

Newsweek Though the recommended age to begin receiving colonoscopies is 45, there has been a noticeable amount of people being diagnosed with colorectal cancer at even younger ages. Wasif Saif, M.D., MBBS , medical oncologist, co-leader of the  Gastrointestinal and Neuroendocrine Oncology Multidisciplinary Team  (MDT) and leader of the  Phase I Clinical Trials MDT , explained the symptoms and risk factors of colorectal cancer that people of average and high-risk need to know, including ho...

101 WRIF November is Lung Cancer Awareness Month. David Sternberg, M.D. , cardiothoracic surgeon and member of the Thoracic Oncology Multidisciplinary Team at Karmanos, spoke to Meltdown on 101 WRIF about lung cancer risks, screening and the advancements in treatment that are available to treat the disease. He described two main causes of lung cancer development: smoking and radon gas. Your browser does not support the audio element. Download Podcast